Valuation Metrics
Financials
Trading Trends
PHAR News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Pharming Group NV (PHAR) stock price today?
The current price of PHAR is 18.7196 USD — it has increased 4.64 % in the last trading day.
What is Pharming Group NV (PHAR)'s business?
Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.
What is the price predicton of PHAR Stock?
Wall Street analysts forecast PHAR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PHAR is 39.50 USD with a low forecast of 37.00 USD and a high forecast of 42.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Pharming Group NV (PHAR)'s revenue for the last quarter?
Pharming Group NV revenue for the last quarter amounts to NaN USD, decreased % YoY.
What is Pharming Group NV (PHAR)'s earnings per share (EPS) for the last quarter?
Pharming Group NV. EPS for the last quarter amounts to USD, decreased % YoY.
What changes have occurred in the market's expectations for Pharming Group NV (PHAR)'s fundamentals?
How many employees does Pharming Group NV (PHAR). have?
Pharming Group NV (PHAR) has 382 emplpoyees as of January 09 2026.
What is Pharming Group NV (PHAR) market cap?
Today PHAR has the market capitalization of 1.25B USD.

![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260108143226_9e81b7df5291f3d9f3758f7414ca932c.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260108200334_fd631ca9cc459953cfe9cd75ca0ad768.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20251230170440_bf4e2d724b810d1db89320c81ca4f194.jpg&w=384&q=75)